All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
CORT total return snapshot: CORT returned +67.69% over the past year and +236.01% YTD, with dividends reinvested. Since Apr. 14, 2004, CORT is up +856.09% in nominal total return, or +10.62%/yr, and is currently −5.37% below its total-return high on Aug. 25, 2026.
Data ending Thu Aug. 27, 2026
| Wed 2004-04-14💬 to Thu 2026-08-27 |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| CORT × |
+856.09%
+10.62%/yr |
+16.32%/yr
R2=0.697 |
||||
| Corcept Therapeutics Incorporated NASDAQ Common Stock | ||||||
| Wed 2004-04-14💬 to Thu 2026-08-27 |
Start
Value |
End
Value |
|---|---|---|
| CORT × |
$10,000.00
2004-04-14 |
$95,609.16
2026-08-27 |
| YTD | YoY | |
|---|---|---|
| CORT × | +236.01% | +67.69% |
|
Current
Drawdown |
Worst
Drawdown |
|
|---|---|---|
| CORT × |
−5.37%
on 2026-08-27 from 2026-08-25 peak |
−94.28%
on 2006-10-13 |
| Period ending Thu 2026-08-27 | 1 yr | 2 yr | 3 yr | 5 yr | 10 yr |
|---|---|---|---|---|---|
| CORT × | +67.69% |
+237.36% +83.67%/yr |
+268.52% +54.46%/yr |
+443.10% +40.27%/yr |
+2,026.00% +35.76%/yr |
| Year | CORT |
|---|---|
| 2026 (YTD) | +236.01% |
| 2025 | −30.94% |
| 2024 | +55.14% |
| 2023 | +59.92% |
| 2022 | +2.58% |
| 2021 | −24.31% |
| 2020 | +116.20% |
| 2019 | −9.43% |
| 2018 | −26.02% |
| 2017 | +148.76% |
| 2016 | +45.78% |
| 2015 | +66.00% |
| 2014 | −6.54% |
| 2013 | +124.48% |
| 2012 | −58.19% |
| 2011 | −11.40% |
| 2010 | +38.85% |
| 2009 | +172.55% |
| 2008 | −66.99% |
| 2007 | +151.22% |
| 2006 | −66.30% |
| 2005 | −41.60% |
| 2004 | −48.90% |